Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 1
1949 3
1950 1
1951 1
1952 1
1955 2
1956 2
1957 2
1958 1
1959 1
1960 3
1961 3
1963 2
1964 4
1965 1
1966 2
1967 8
1968 5
1969 1
1970 4
1971 2
1972 2
1973 2
1974 6
1975 2
1976 5
1977 3
1978 7
1979 10
1980 5
1981 3
1982 4
1983 1
1984 5
1985 1
1986 1
1987 2
1988 1
1989 1
1990 7
1991 5
1992 4
1993 3
1994 7
1995 5
1996 6
1997 8
1998 13
1999 15
2000 10
2001 13
2002 11
2003 11
2004 14
2005 22
2006 19
2007 8
2008 10
2009 6
2010 22
2011 26
2012 22
2013 26
2014 29
2015 36
2016 24
2017 24
2018 30
2019 25
2020 33
2021 35
2022 32
2023 36
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

641 results

Results by year

Filters applied: . Clear all
Page 1
A defined diet for pre-adult Drosophila melanogaster.
Martelli F, Quig A, Mele S, Lin J, Fulton TL, Wansbrough M, Barlow CK, Schittenhelm RB, Johnson TK, Piper MDW. Martelli F, et al. Among authors: barlow ck. Sci Rep. 2024 Mar 23;14(1):6974. doi: 10.1038/s41598-024-57681-z. Sci Rep. 2024. PMID: 38521863 Free PMC article.
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage.
Pena N, Richbourg T, Gonzalez-Hunt CP, Qi R, Wren P, Barlow C, Shanks NF, Carlisle HJ, Sanders LH. Pena N, et al. Among authors: barlow c. NPJ Parkinsons Dis. 2024 Mar 1;10(1):49. doi: 10.1038/s41531-024-00660-y. NPJ Parkinsons Dis. 2024. PMID: 38429321 Free PMC article.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
641 results